Literature DB >> 17894191

Promoting adherence to treatment for tuberculosis: the importance of direct observation.

Thomas R Frieden1, John A Sbarbaro.   

Abstract

Since 1993, WHO has recommended a strategy through which national governments can meet their responsibility to treat patients and to prevent the spread of tuberculosis (TBI). Four of the major elements of the strategy, which came to be known as DOTS, were political commitment by governments, improved laboratory services, a continuous supply of good-quality drugs, and a reporting system to document the progress (and failure) of treatment for individual patients and of the programme. The fifth element, effective case management via direct observation of treatment by an independent and trained third party, was a response to decades of reports documenting the failure of patients to complete treatment. Put simply: direct observation of treatment is an integral and essential component of DOTS. The value of the direct observation component of DOTS has been questioned in a recent systematic review, in which it was suggested that direct observation of treatment is unnecessary and disrespectful of patients. Both self-administered treatment and treatment observation by a family member have been proposed as acceptable alternatives. This article challenges the validity of these assertions on the basis that, firstly, direct observation requires strong leadership and a lengthy commitment of human resources, which as yet is not universally employed. Secondly, it is believed that the ultimate ethical and legal responsibility for ensuring treatment completion and cure of a communicable disease belongs to the public health system and the community, and not to the individual patient. TB, this article will seek to argue, can be controlled when appropriate policies are implemented and continued, even in the absence of an outbreak or media attention. Just as patients may be tempted to change or stop an effective treatment regimen because of the long duration of treatment, public health policy-makers may be tempted to alter key elements of DOTS because of the persistence required to maintain effective programmes.

Entities:  

Year:  2007        PMID: 17894191

Source DB:  PubMed          Journal:  World Hosp Health Serv        ISSN: 1029-0540


  13 in total

1.  Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Deborah Banks-Tripp; Sarah Hashmi; Carrie Kujoth; Dean Schraufnagel
Journal:  Eur Respir J       Date:  2015-03-18       Impact factor: 16.671

2.  Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.

Authors:  Tan N Doan; Pengxing Cao; Theophilus I Emeto; James M McCaw; Emma S McBryde
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 3.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

4.  Listening to Those at the Frontline: Patient and Healthcare Personnel Perspectives on Tuberculosis Treatment Barriers and Facilitators in High TB Burden Regions of Argentina.

Authors:  Sarah J Iribarren; Fernando Rubinstein; Vilda Discacciati; Patricia F Pearce
Journal:  Tuberc Res Treat       Date:  2014-09-28

5.  High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?

Authors:  Romain Ragonnet; James M Trauer; Justin T Denholm; Ben J Marais; Emma S McBryde
Journal:  BMC Infect Dis       Date:  2017-01-06       Impact factor: 3.090

6.  A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosis.

Authors:  Romain Ragonnet; James M Trauer; Justin T Denholm; Ben J Marais; Emma S McBryde
Journal:  BMC Infect Dis       Date:  2017-05-30       Impact factor: 3.090

7.  The role of agency in the implementation of Isoniazid Preventive Therapy (IPT): Lessons from oMakoti in uMgungundlovu District, South Africa.

Authors:  Jody Boffa; Maria Mayan; Sithembile Ndlovu; Tsholofelo Mhlaba; Tyler Williamson; Reginald Sauve; Dina Fisher
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

8.  A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

9.  Nurses' Roles and Experiences with Enhancing Adherence to Tuberculosis Treatment among Patients in Burundi: A Qualitative Study.

Authors:  Marie Carlsson; Stina Johansson; Remy-Paul Bosela Eale; Berthollet Bwira Kaboru
Journal:  Tuberc Res Treat       Date:  2014-08-19

Review 10.  Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.

Authors:  Jia Yin; Jinqiu Yuan; Yanhong Hu; Xiaolin Wei
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.